Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECIDE Study
2015-001873-42Phase 4Unknown
- Sponsor
- University of Liverpool
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Dapagliflozin arm with Standard of care arm (2 arms). Primary endpoints: Composite clinical success at approximately 52 weeks, Composite clinical success within first 52 weeks and 1 more. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-001873-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001873-42.